Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Molecular phylogeny of the ETS gene family

Abstract

We have constructed a molecular phylogeny of the ETS gene family. By distance and parsimony analysis of the ETS conserved domains we show that the family containing so far 29 different genes in vertebrates can be divided into 13 groups of genes namely ETS, ER71, GABP, PEA3, ERG, ERF, ELK, DETS4, ELF, ESE, TEL, YAN, SPI. Since the three dimensional structure of the ETS domain has revealed a similarity with the winged-helix – turn – helix proteins, we used two of them (CAP and HSF) to root the tree. This allowed us to show that the family can be divided into five subfamilies: ETS, DETS4, ELF, TEL and SPI. The ETS subfamily comprises the ETS, ER71, GABP, PEA3, ERG, ERF and the ELK groups which appear more related to each other than to any other ETS family members. The fact that some members of these subfamilies were identified in early metazoans such as diploblasts and sponges suggests that the diversification of ETS family genes predates the diversification of metazoans. By the combined analysis of both the ETS and the PNT domains, which are conserved in some members of the family, we showed that the GABP group, and not the ERG group, is the one most closely related to the ETS group. We also observed that the speed of accumulation of mutations in the various genes of the family is highly variable. Noticeably, paralogous members of the ELK group exhibit strikingly different evolutionary speed suggesting that the evolutionary pressure they support is very different.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4

Similar content being viewed by others

References

  • Alkema MJ, Bronk M, Verhoeven E, Otte A, van't Veer LJ, Berns A and van Lohuizen M. . 1996 Genes & Dev. 11: 226–240.

  • Averof M. . 1997 Curr. Biol. 7: R634–R636.

  • Bassuk AG and Leiden JM. . 1995 Immunity 3: 223–237.

  • Basuyaux JP, Ferreira E, Stéhelin D and Butticé G. . 1997 J. Biol. Chem. 272: 26188–26195.

  • Beitel GJ, Tuck S, Greenwald I and Horvitz HR. . 1995 Genes Dev. 9: 3149–3162.

  • Ben-David Y, Giddens EB, Letwin K and Bernstein A. . 1991 Genes Dev. 5: 908–918.

  • Bories JC, Willeford DM, Grévin D, Davidson L, Camus A, Martin P, Stéhelin D and Alt FW. . 1995 Nature 377: 635–638.

  • Borneman D, Miller E and Simon J. . 1996 Development 122: 1621–1630.

  • Butticé G, Duterque-Coquillaud M, Basuyaux JP, Carrère S, Kurkinen M and Stéhelin D. . 1996 Oncogene 13: 2297–2306.

  • Carrère S, Verger A, Flourens A, Stéhelin D and Duterque-Coquillaud M. . 1998 Oncogene 16: 3261–3268.

  • Chen T, Bunting M, Karim FD and Thummel CS. . 1992 Dev. Biol. 151: 176–191.

  • Crépieux P, Coll J and Stéhelin D. . 1994 Crit. Rev. Oncology 5: 615–638.

  • Dalton S and Treisman R. . 1992 Cell. 68: 597–612.

  • Degnan BM, Degnan SM, Nagagnuma T and Morse DE. . 1993 Nucl. Ac. Res. 21: 3479–3484.

  • Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, De Jong P, Rouleau G, Aurias A and Thomas G. . 1992 Nature 359: 162–165.

  • Donalson LW, Petersen JM, Graves BJ and McIntosh LP. . 1994 Biochemistry 33: 13509–13516.

  • Donalson LW, Petersen JM, Graves BJ and McIntosh LP. . 1996 EMBO J. 15: 125–134.

  • Duterque-Coquillaud M, Niel C, Plaza S and Stéhelin D. . 1993 Oncogene 8: 1865–1873.

  • Escriva, H., Safi R., Hänni C, Langlois MC, Saumitou-Laprade P, Stéhelin D, Capron A, Pierce R and Laudet V. . 1997 Proc. Natl. Acad. Sci. USA 94: 6803–6808.

  • Fitzsimmons D, Hodsdon W, Wheat W, Maira SM, Wasylyk B and Hagman J. . 1996 Genes Dev. 10: 2198–2211.

  • Golub TR, Barker GF, Lovett M and Gilliland G. . 1994 Cell. 77: 307–316.

  • Graves BJ and Petersen JM. . 1998 Adv. Cancer Res. 75: 1–55.

  • Hipskind RA, Rao VN, Mueller CGF, Reddy ESP and Nordheim A. . 1991 Nature 354: 531–534.

  • Holland PW and Garcia-Fernandez J. . 1996 Dev. Biol. 173: 382–395.

  • Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT and Shapiro DN. . 1995 Oncogene 10: 1229–1234.

  • Jousset C, Carron C, Boureux A, Tran Quang C, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O and Ghysdael J. . 1997 EMBO J. 16: 69–82.

  • Karim FD, Urness LD, Thummel CS, Klemsz MJ, Mc Kercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV, Nye JA and Graves BJ. . 1990 Genes Dev. 4: 1451–1453.

  • Kasahara M, Hayashi M, Tanaka K, Inoku H, Sugaya K, Ikemura T and Ishibashi T. . 1996 Proc. Natl. Acad. Sci. USA 93: 9096–9101.

  • Katsanis N, Fitzgibbon J and Fisher EMC. . 1996 Genomics 35: 101–108.

  • Kherrouche Z, Beuscart A, Huguet C, Flourens A, Moreau-Gachelin F, Stéhelin D and Coll J. . 1998 Oncogene 16: 1357–1367.

  • Klämbt C. . 1993 Development 117: 163–176.

  • Kodandapani R, Pio F, Picciali G, Klemsz M, McKercher S, Maki RA and Ely KR. . 1996 Nature 380: 456–460.

  • Landsman D and Wolffe AP. . 1995 TIBS 20: 225–226.

  • Laudet V. . 1997 J. Mol. Endocrinol. 19: 207–226.

  • Laudet V, Niel C, Duterque-Coquillaud M, Leprince D and Stéhelin D. . 1993 Biochem. Biophys. Res. Com. 190: 8–14.

  • Lautenberger JA, Burdett LA, Gunnell MA, Shengmei Q, Watson DK, O'Brien SJ and Papas TS. . 1992 Oncogene 7: 1713–1719.

  • Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C and Stéhelin D. . 1983 Nature 306: 395–397.

  • Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, Thompson CB and Fesik SW. . 1994 Nature Struct. Biol. 1: 871–875.

  • Maira S-M, Wurtz J-M and Wasylyk B. . 1996 EMBO J. 15: 5849–5865.

  • McKay DB and Steitz TA. . 1981 Nature 290: 744–749.

  • Moreau-Gachelin F, Ray D, Mattei MG, Tambourin P and Tavitian A. . 1989 Oncogene 4: 1449–1456.

  • Muthusamy N, Barton K and Leiden JM. . 1995 Nature 377: 639–642.

  • Nunn MF, Seeburg PH, Moscovici C and Duesberg PH. . 1983 Nature 306: 391–395.

  • Ohno S. . 1970 Evolution by gene duplication. Springer-Verlag: Heidelberg.

  • Papadopoulos P, Ridge SA, Boucher CA, Stocking C and Wiedemann LM. . 1995 Cancer Res. 55: 34–38.

  • Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H and Delattre O. . 1997 Oncogene 14: 1159–1164.

  • Philippe H, Chenul A and Adoutte A. . 1994 Development suppl 15–25.

  • Pongubala JMR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA and Atchison ML. . 1992 Mol. Cell. Biol. 12: 368–378.

  • Pongulaba JMR and Atchison ML. . 1997 Proc. Natl. Acad. Sci. USA 94: 127–132.

  • Price MA, Rogers AE and Treisman R. . 1995 EMBO J. 14: 2589–2601.

  • Rao VN, Modi WS, Drabkin HD, Patterson D, O'Brien SJ, Papas TS and Reddy ESP. . 1988 Oncogene 3: 497–500.

  • Rao VN, Papas TS and Reddy ESP. . 1987 Science 237: 635–639.

  • Rivera RR, Stuiver MH, Steenberger R and Murre C. . 1993 Mol. Cell. Biol. 13: 7163–7169.

  • Rorth P, Nerlov C, Blasi F and Jonhsen M. . 1990 Nucleic Acids Res. 18: 5009–5017.

  • Scott EW, Simon MC, Anastasi J and Singh H. . 1994 Science 265: 1573–1577.

  • Seth A and Papas TS. . 1990 Oncogene 5: 1761–1767.

  • Sgouras DN, Athanasiou MA, Beal Jr GL, Fisher RJ, Blair DG and Mavrothalassitis GJ. . 1995 EMBO J. 14: 4781–4793.

  • Shimizu K, Ichikawa H, Tojo A, Kaneno Y, Maseki N, Hayashi Y, Ohira M, Asano S and Ohki M. . 1993 Proc. Natl. Acad. Sci. USA 90: 10280–10284.

  • Shore P and Shazzocks AD. . 1995 Nucl. Acids Res. 23: 4698–4707.

  • Sorensen PH, Lessnick SL, Lopez TD, Liu XF, Triche TJ and Denny CT. . 1994 Nat. Genet. 6: 146–151.

  • Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R and Teitelbaum SL. . 1997 Nature 386: 81–84.

  • Urano F, Umezawa A, Hong W, Kikuchi H, and Hata JH. . 1996 Biochem. Biophys. Res. Comm. 219: 608–612.

  • Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stéhelin D. . 1989 Development 106: 265–274.

  • Vernier P, Cardinaud B, Valdenaire O, Philippe H and Vincent J-D. . 1995 Trends Pharmacol. Sci. 16: 375–376.

  • Wang CY, Petryniak B, Ho IC, Thompson CB and Leiden JM. . 1992 J. Exp. Med. 175: 1391–1399.

  • Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D and Stéhelin D. . 1990 Nature 346: 191–193.

  • Wasylyk C, Gutman A, Nicholson R and Wasylyk B. . 1991 EMBO J. 10: 1127–1134.

  • Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW and Papas TS. . 1988 Proc. Natl. Acad. Sci. USA 85: 7862–7866.

  • Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G & Delattre O. . 1993 EMBO J. 12: 4481–4487.

Download references

Acknowledgements

We thank Yvan de Launoit for unpublished sequences, Séverine Carrère, Pascale Crépieux, Jean Coll, François Morlé and Daniel Regnier for critical reading of the manuscript, B Graves and L McIntosh for communicating results prior to publication and CNRS, ARC, GREG and IPL for financial support.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laudet, V., Hänni, C., Stéhelin, D. et al. Molecular phylogeny of the ETS gene family. Oncogene 18, 1351–1359 (1999). https://doi.org/10.1038/sj.onc.1202444

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202444

Keywords

This article is cited by

Search

Quick links